Literature DB >> 10627861

Pregnancy outcome in women with insulin-dependent diabetes mellitus complicated by nephropathy.

F P Dunne1, T A Chowdhury, A Hartland, T Smith, P A Brydon, C McConkey, H O Nicholson.   

Abstract

We retrospectively analysed pregnancy complicated by diabetic nephropathy in patients attending a University teaching hospital (1990-97), to examine fetal/maternal outcomes. Fetal outcomes included early intrauterine deaths, stillbirths, neonatal/perinatal mortality, size for gestational age, malformations, and need for neonatal unit care. Maternal outcomes included change in frequency of hypertension or severe proteinuria, serum creatinine data, and caesarean section rate. There were 21 pregnancies in 18 women, resulting in 21 live infants. Neonatal mortality (RR 10, 95% CI 0-3.9), perinatal mortality (RR 5, 95% CI 0-3.3) and congenital malformations (RR 5.0, 95% CI 0.3-26.3) were greater than in the background population. At delivery, 76% of babies were appropriate in size for gestational age; 57% were preterm, all of whom required neonatal unit care. The caesarean section rate was 90.5% vs. 20% in the background population (RR 4.5, 95% CI 3.4-5.0) (p < 0.05). Hypertension frequency (p < 0.001) and high-grade proteinuria (p < 0.05) increased from booking to delivery. Although the take-home baby rate was 90%, perinatal/neonatal mortality, congenital malformations and caesarean sections, in addition to maternal morbidity, were significantly higher in women with diabetic nephropathy than in the background population.

Entities:  

Mesh:

Year:  1999        PMID: 10627861     DOI: 10.1093/qjmed/92.8.451

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  13 in total

Review 1.  Congenital malformations in offspring of diabetic mothers--animal and human studies.

Authors:  Ulf J Eriksson; Jonas Cederberg; Parri Wentzel
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

2.  Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study.

Authors:  R Bell; S V Glinianaia; P W G Tennant; R W Bilous; J Rankin
Journal:  Diabetologia       Date:  2012-02-08       Impact factor: 10.122

Review 3.  Type 1 diabetes, diabetic nephropathy, and pregnancy: a systematic review and meta-study.

Authors:  Giorgina Barbara Piccoli; Roberta Clari; Sara Ghiotto; Natascia Castelluccia; Nicoletta Colombi; Giuseppe Mauro; Elisabetta Tavassoli; Carmela Melluzza; Gianfranca Cabiddu; Giuseppe Gernone; Elena Mongilardi; Martina Ferraresi; Alessandro Rolfo; Tullia Todros
Journal:  Rev Diabet Stud       Date:  2013-05-10

4.  Obstetric and perinatal outcome in type 1 diabetes patients with diabetic nephropathy during 1988-2011.

Authors:  Miira M Klemetti; Hannele Laivuori; Minna Tikkanen; Mika Nuutila; Vilho Hiilesmaa; Kari Teramo
Journal:  Diabetologia       Date:  2015-01-10       Impact factor: 10.122

Review 5.  Pregnancy in women with diabetic nephropathy.

Authors:  Donatella Spotti
Journal:  J Nephrol       Date:  2018-11-15       Impact factor: 3.902

6.  Improved pregnancy outcome in type 1 diabetic women with microalbuminuria or diabetic nephropathy: effect of intensified antihypertensive therapy?

Authors:  Lene Ringholm Nielsen; Peter Damm; Elisabeth R Mathiesen
Journal:  Diabetes Care       Date:  2008-10-22       Impact factor: 19.112

Review 7.  Diabetic Nephropathy in Women With Preexisting Diabetes: From Pregnancy Planning to Breastfeeding.

Authors:  Lene Ringholm; Julie Agner Damm; Marianne Vestgaard; Peter Damm; Elisabeth R Mathiesen
Journal:  Curr Diab Rep       Date:  2016-02       Impact factor: 4.810

Review 8.  Improving pregnancy outcomes in women with diabetes mellitus: modern management.

Authors:  Lene Ringholm; Peter Damm; Elisabeth R Mathiesen
Journal:  Nat Rev Endocrinol       Date:  2019-07       Impact factor: 43.330

9.  Diabetic nephropathy and microalbuminuria in pregnant women with type 1 and type 2 diabetes: prevalence, antihypertensive strategy, and pregnancy outcome.

Authors:  Julie Agner Damm; Björg Asbjörnsdóttir; Nicoline Foged Callesen; Jonathan M Mathiesen; Lene Ringholm; Berit Woetmann Pedersen; Elisabeth R Mathiesen
Journal:  Diabetes Care       Date:  2013-09-05       Impact factor: 19.112

10.  Specific local cardiovascular changes of Nepsilon-(carboxymethyl)lysine, vascular endothelial growth factor, and Smad2 in the developing embryos coincide with maternal diabetes-induced congenital heart defects.

Authors:  Pauline A M Roest; Daniël G M Molin; Casper G Schalkwijk; Liesbeth van Iperen; Parri Wentzel; Ulf J Eriksson; Adriana C Gittenberger-de Groot
Journal:  Diabetes       Date:  2009-02-02       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.